Carolyne Falank1,2,3, Heather Fairfield1,2,3, Michaela R Reagan1,2,3. 1. Maine Medical Research Institute, Scarborough, ME, USA. 2. University of Maine, Orono, ME, USA. 3. Tufts University School of Medicine, Boston, MA, USA.
Abstract
This review highlights the recent advances in our understanding of adipocyte contributions to carcinogenesis or cancer disease progression for cancers in the bone. PURPOSE: In this review, we aim to describe bone marrow adipose tissue and discuss the soluble adipocyte-derived cytokines (adipokines) or endocrine factors, adipocyte-derived lipids, and the actual or putative juxtacrine signaling between bone marrow adipocytes and tumor cells in the bone marrow. This relationship likely affects tumor cell initiation, proliferation, metastasis, and/or drug resistance. RECENT FINDINGS: Bone marrow adipose may affect tumor proliferation, drug resistance, or cancer-induced bone disease and hence may be a new target in the fight against cancer. SUMMARY: Overall, evidence is mixed regarding the role of bone marrow adipose and adipocytes in cancer progression, and more research in this arena is necessary to determine how these bone marrow microenvironmental cells contribute to malignancies in the marrow to identify novel, potentially targetable pathways.
This review highlights the recent advances in our understanding of adipocyte contributions to carcinogenesis or cancer disease progression for cancers in the bone. PURPOSE: In this review, we aim to describe bone marrow adipose tissue and discuss the soluble adipocyte-derived cytokines (adipokines) or endocrine factors, adipocyte-derived lipids, and the actual or putative juxtacrine signaling between bone marrow adipocytes and tumor cells in the bone marrow. This relationship likely affects tumor cell initiation, proliferation, metastasis, and/or drug resistance. RECENT FINDINGS: Bone marrow adipose may affect tumor proliferation, drug resistance, or cancer-induced bone disease and hence may be a new target in the fight against cancer. SUMMARY: Overall, evidence is mixed regarding the role of bone marrow adipose and adipocytes in cancer progression, and more research in this arena is necessary to determine how these bone marrow microenvironmental cells contribute to malignancies in the marrow to identify novel, potentially targetable pathways.
Entities:
Keywords:
Adipokine; Bone Marrow Adipocytes; Bone Marrow Adipose Tissue; Cancer
Authors: Yi Fan; Jun-Ichi Hanai; Phuong T Le; Ruiye Bi; David Maridas; Victoria DeMambro; Carolina A Figueroa; Serkan Kir; Xuedong Zhou; Michael Mannstadt; Roland Baron; Roderick T Bronson; Mark C Horowitz; Joy Y Wu; John P Bilezikian; David W Dempster; Clifford J Rosen; Beate Lanske Journal: Cell Metab Date: 2017-02-02 Impact factor: 27.287
Authors: Michelle M McDonald; Michaela R Reagan; Scott E Youlten; Sindhu T Mohanty; Anja Seckinger; Rachael L Terry; Jessica A Pettitt; Marija K Simic; Tegan L Cheng; Alyson Morse; Lawrence M T Le; David Abi-Hanna; Ina Kramer; Carolyne Falank; Heather Fairfield; Irene M Ghobrial; Paul A Baldock; David G Little; Michaela Kneissel; Karin Vanderkerken; J H Duncan Bassett; Graham R Williams; Babatunde O Oyajobi; Dirk Hose; Tri G Phan; Peter I Croucher Journal: Blood Date: 2017-05-17 Impact factor: 22.113
Authors: Manar S Shafat; Thomas Oellerich; Sebastian Mohr; Stephen D Robinson; Dylan R Edwards; Christopher R Marlein; Rachel E Piddock; Matthew Fenech; Lyubov Zaitseva; Amina Abdul-Aziz; Jeremy Turner; Johnathan A Watkins; Matthew Lawes; Kristian M Bowles; Stuart A Rushworth Journal: Blood Date: 2017-01-03 Impact factor: 22.113